Adverse Drug Events Completed Phase 3 Trials for Capecitabine (DB01101)

Also known as: Adverse Drug Event

IndicationStatusPhase
DBCOND0029335 (Adverse Drug Events)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01080547Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal CancerTreatment